Clik here to view.
HistoSonics成功加入英国新创新计划
明尼阿波利斯 (美国商业资讯)– Edison ®系统和创新组织摧毁术治疗平台制造商HistoSonics®（www.histosonics.com）...
View ArticleClik here to view.
ヒストソニックス、英国の新しいイノベーションプログラムIDAPに参加
MINNEAPOLIS （ビジネスワイヤ） — ヒストソニックス ® （ www.histosonics.com ）は、Edison ® システムのメーカーであり、画期的なヒストトリプシー療法のプラットフォームです。このほど、当社のEdisonシステムは、英国で新たに立ち上げられた Innovative Devices Access Pathway（IDAP）パイロットプログラム...
View ArticleClik here to view.
AI Medical Service Inc. Completes First Regulatory Review and Device...
TOKYO AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce the first instance of Singaporean regulatory...
View ArticleClik here to view.
BiVACOR® Receives $13 Million to Support Clinical Trials for the Company’s...
GOLD COAST, Australia & HUNTINGTON BEACH, Calif. BiVACOR®, a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research...
View ArticleClik here to view.
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that a group of prominent cervical cancer doctors are in the final...
View ArticleClik here to view.
AI Medical Service Inc.完成新加坡HSA对基于胃人工智能的内窥镜诊断支持系统的首次监管审查和器械注册
东京 (美国商业资讯)– AI MEDICAL SERVICE INC.（以下简称“AIM”）是一家专门从事内窥镜人工智能诊断开发的医疗初创公司。该公司欣然宣布，基于人工智能并在胃内部进行内窥镜诊断支持的器械已通过新加坡监管部门的首次审查和器械注册（品牌名称：内窥镜影像诊断支持软件- gastroAI-model...
View ArticleClik here to view.
MMI、シリーズC資金調達で1億1000万ドルを調達
フロリダ州ジャクソンビル （ビジネスワイヤ） — 複雑な病状を抱える患者の治療選択肢を増やし、臨床転帰の改善に取り組むロボット企業のMMI (Medical Microinstruments,...
View ArticleClik here to view.
MMI在 C 轮融资中筹资1.1亿美元
杰克逊维尔，佛罗里达州 (美国商业资讯)– MMI（Medical Microinstruments, Inc.），一家专注于通过机器人技术增加治疗方案并改善复杂病症患者的临床结果的公司，今日宣布成功完成1.1亿美元的C轮融资。该轮融资由富达管理研究公司（Fidelity Management & Research...
View ArticleClik here to view.
MMI Raises $110 Million in Series C Financing
JACKSONVILLE, Fla. MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today...
View ArticleClik here to view.
Novo Integrated Sciences Subsidiary, Clinical Consultants International,...
BELLEVUE, Wash. Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International, LLC (“CCI”), a Novo wholly-owned subsidiary, today announced the...
View ArticleClik here to view.
Caldera Medical’s Humanitarian Effort Reaches New Heights: 400,000 Women...
LOS ANGELES Caldera Medical, renowned for its dedication to improving the quality of life for women, has announced significant milestones in its global humanitarian program. In partnership with...
View ArticleClik here to view.
New Swiss Made Features for Cataract Surgery Lens Selection
NEUCHATEL, Switzerland The company Swiss Advanced Vision (SAV-IOL SA) has announced the launch of New Features for its Toric Calculator improving the overall calculation experience. For the...
View ArticleClik here to view.
白内障手术镜片选择的新瑞士制造特性
瑞士, 纳沙泰尔 (美国商业资讯)– Swiss Advanced Vision （SAV-IOL SA）宣布推出其扭曲计算器的新功能，以改善整体计算体验。眼科医生首次能够利用基于患者光学参数的网络配置器来帮助确定最佳的切口位置，以最小化手术后残留的散光。而且，适用于所有类型的镜片。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Clik here to view.
MHRA Issues Notice of Acceptance for POLARIS-AD, a Phase 3 Early Alzheimer’s...
SEONGNAM-SI, South Korea AriBio Co., Ltd. (AriBio) receives Notice of Acceptance for POLARIS-AD, a Phase 3 early Alzheimer’s disease clinical trial from the Medicines and Healthcare Products...
View ArticleClik here to view.
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in...
REDWOOD CITY, Calif. Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD), today...
View ArticleClik here to view.
MHRA签发AriBio Co., Ltd赞助的早期阿尔茨海默病第三期临床试验POLARIS-AD的受理通知
韩国城南市 (美国商业资讯)– AriBio Co., Ltd.（AriBio）收到英国药品和保健品监管局 （MHRA）签发的早期阿尔茨海默病第三期临床试验POLARIS-AD的受理通知。MHRA于2月21日完成审查并确认了有利的道德意见，公司预计于2024年第一季度末之前在英国启动该临床试验。...
View ArticleClik here to view.
Mainstay Medical Announces US$125 Million Equity Financing Transaction
DUBLIN Mainstay Medical Holdings plc today announced an equity financing in which it will receive gross proceeds of US$125 million. Mainstay intends to use the funds to support the company’s...
View ArticleClik here to view.
富士胶片欧文科技产品在华获批，扩展在华辅助生殖技术产品组合
加利福尼亚州，圣安娜 (美国商业资讯)– 富士胶片欧文科技是全球生命科学和医疗市场细胞培养解决方案的创新和制造领域的领导者。随着中国国家药品监督管理局（NMPA）批准了公司的三款产品——胚胎培养液（CSCM-C）、胚胎培养油和精子冻存液，公司今天宣布了其在中国的辅助生殖技术（ART）产品组合得到了扩展。这些新产品代表了该地区的主要市场增长机会，以响应对公司全套培养基解决方案和体外受精...
View ArticleClik here to view.
Foldax, Inc. Signs Manufacturing Agreement with Dolphin Life Science India...
SALT LAKE CITY Foldax® Inc., a pioneer in the development of innovative, polymer heart valves, today announced a manufacturing agreement with Dolphin Life Science India LLP to enable in-country...
View Article